GL1X · GenesisL1 explorer

MolNFT v1 · #179624 · protein

The crystal structure of the 2009/H1N1/CALIFORNIA pa endonuclease mutant E119D (construct with truncated loop 51-72) in complex with baloxavir acid

7KBC · Protein pa-X: “The crystal structure of the 2009/H1N1/CALIFORNIA pa endonuclease mutant E119D (construct with truncated loop…”. X-ray diffraction, 4 ligands (E4Z, QQ4, MN), 1 pocket (best druggability 0.63). MolNFT v1 #179624 on…

PDB
7KBC
Type
protein
Length
180 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein pa-X
UniProt
A0A4P2TE19, C6H0Y9
Ligands
E4Z, QQ4, MN, SO4
Pockets
1 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 54% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein pa-Xprotein18054% helix, 13% strandA0A4P2TE19, C6H0Y9

Ligands and binding sites

  • E4Z · Baloxavir acid · ligand · chains A
  • QQ4 · Hexa Vinylpyrrolidone K15 · ligand · chains A
  • MN · Manganese (II) ion · metal · 2 copies · chains A
  • SO4 · Sulfate ion · ion · chains A
  • GOL · Glycerol · additive · 5 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14100.630.7738E4Z, GOL, MN

Compared structures

  • 7KBC · The crystal structure of the 2009/H1N1/California PA endonuclease mutant E119D (construct… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.